DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.59	3.03	4.54	4.73	4.71	7.41
Short-Term Investments	33.93	41.12	48.35	28.77	40.41	20.1
Cash & Short-Term Investments	36.52	44.15	52.9	33.5	45.11	27.51
Cash Growth	-21.49%	-16.54%	57.89%	-25.74%	64.00%	249.16%
Other Receivables	0.25	0.24	0.37	0.08	0.13	0.34
Receivables	0.25	0.24	0.37	0.08	0.13	0.34
Prepaid Expenses	0.65	0.23	0.41	0.21	0.08	0.06
Other Current Assets	-	-	-	0.04	0.11	0.01
Total Current Assets	37.42	44.61	53.68	33.84	45.44	27.92
Property, Plant & Equipment	0.41	0.43	0.49	0.56	0.11	0.17
Other Long-Term Assets	-	1.31	-	-	-	-
Total Assets	38.83	46.35	54.16	34.4	45.55	28.1
Accounts Payable	1.51	0.94	0.93	0.73	0.51	1.1
Accrued Expenses	3.05	4.35	1.78	1.37	0.97	0.86
Current Portion of Leases	0.11	0.1	0.08	0.07	0.05	0.07
Total Current Liabilities	4.67	5.39	2.79	2.17	1.52	2.03
Long-Term Leases	0.21	0.24	0.32	0.4	0	0.05
Total Liabilities	4.88	5.63	3.1	2.57	1.53	2.08
Additional Paid-In Capital	181.66	180.7	166.61	128.08	126.58	94.93
Retained Earnings	-147.71	-140	-115.56	-96.18	-82.5	-68.91
Comprehensive Income & Other	0.01	0.02	0.01	-0.07	-0.05	-0
Shareholders' Equity	33.95	40.72	51.06	31.83	44.02	26.01
Total Liabilities & Equity	38.83	46.35	54.16	34.4	45.55	28.1
Total Debt	0.32	0.34	0.4	0.47	0.05	0.12
Net Cash (Debt)	37.2	43.81	52.5	33.03	45.06	27.39
Net Cash Growth	-19.36%	-16.55%	58.92%	-26.69%	64.52%	255.70%
Net Cash Per Share	0.89	1.08	1.61	1.25	2.17	1.75
Filing Date Shares Outstanding	42.88	42.86	37.96	26.46	26.44	18.78
Total Common Shares Outstanding	42.86	42.82	37.96	26.44	26.44	18.75
Working Capital	32.76	39.22	50.89	31.67	43.92	25.89
Book Value Per Share	0.79	0.95	1.35	1.20	1.66	1.39
Tangible Book Value	33.95	40.72	51.06	31.83	44.02	26.01
Tangible Book Value Per Share	0.79	0.95	1.35	1.20	1.66	1.39
Machinery	-	0.25	0.22	0.2	0.14	0.13
Leasehold Improvements	-	0.02	0.02	0.02	0	-

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q